SIRT2 and metabolic dysfunction-associated steatotic liver disease: In our study, the SIRT2 KO mice exhibited significantly declined hepatoprotective metabolites (PC, LPC, and epinephrine) and elevated harmful metabolites (l-proline), demonstrating that SIRT2 deficiency may promote NAFLD progression through metabolic disorders.